{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:53:56Z","timestamp":1770814436155,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["DOK-2021-02-4995"],"award-info":[{"award-number":["DOK-2021-02-4995"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["UIP-2019-04-8461"],"award-info":[{"award-number":["UIP-2019-04-8461"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0021"],"award-info":[{"award-number":["KK.01.1.1.02.0021"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00216-025-06233-z","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:34:37Z","timestamp":1763418877000},"page":"793-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surfactant-enhanced emulsification liquid-liquid microextraction combined with sweeping micellar electrokinetic chromatography-tandem mass spectrometry for therapeutic drug monitoring of alpelisib and fulvestrant in human plasma"],"prefix":"10.1007","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-2461","authenticated-orcid":false,"given":"Zvonimir","family":"Mlinari\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-5859","authenticated-orcid":false,"given":"Lu","family":"Turkovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-5921","authenticated-orcid":false,"given":"Biljana","family":"Nigovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-672X","authenticated-orcid":false,"given":"Miranda","family":"Serti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"6233_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"6233_CR2","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1634\/theoncologist.2019-0729","volume":"25","author":"AN Shah","year":"2020","unstructured":"Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M. Hormone Receptor\u2013Positive\/Human Epidermal Growth Receptor 2\u2013Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents. Oncologist. 2020;25:e900\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2019-0729.","journal-title":"Oncologist"},{"key":"6233_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/S40265-019-01161-6","volume":"79","author":"A Markham","year":"2019","unstructured":"Markham A. Alpelisib: first global approval. Drugs. 2019;79:1249\u201353. https:\/\/doi.org\/10.1007\/S40265-019-01161-6.","journal-title":"Drugs"},{"key":"6233_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/J.ANNONC.2020.11.011","volume":"32","author":"F Andr\u00e9","year":"2021","unstructured":"Andr\u00e9 F, Ciruelos EM, Juric D, Loibl S, Campone M, Mayer IA, Rubovszky G, Yamashita T, Kaufman B, Lu YS, Inoue K, P\u00e1pai Z, Takahashi M, Ghaznawi F, Mills D, Kaper M, Miller M, Conte PF, Iwata H, Rugo HS. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2\u2013negative advanced breast cancer: final overall survival results from SOLAR-1. Ann Oncol. 2021;32:208\u201317. https:\/\/doi.org\/10.1016\/J.ANNONC.2020.11.011.","journal-title":"Ann Oncol"},{"key":"6233_CR5","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1002\/CNCR.34928","volume":"129","author":"S Shen","year":"2023","unstructured":"Shen S, Chen Y, Carpio A, Chang C, Iyengar NM. Incidence, risk factors, and management of alpelisib-associated hyperglycemia in metastatic breast cancer. Cancer. 2023;129:3854\u201361. https:\/\/doi.org\/10.1002\/CNCR.34928.","journal-title":"Cancer"},{"key":"6233_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/S10549-021-06476-1","volume":"192","author":"YMM Cheung","year":"2022","unstructured":"Cheung YMM, Cromwell GE, Tolaney SM, Min L, McDonnell ME. Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer. Breast Cancer Res Treat. 2022;192:303\u201311. https:\/\/doi.org\/10.1007\/S10549-021-06476-1.","journal-title":"Breast Cancer Res Treat"},{"key":"6233_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins BD, Pauli C, Xing D, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR, Bareja R, Ma Y, Harris EM, Sboner A, Beltran H, Rubin MA, Mukherjee S, Cantley LC. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560:499\u2013503. https:\/\/doi.org\/10.1038\/s41586-018-0343-4.","journal-title":"Nature"},{"key":"6233_CR8","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1016\/J.CLBC.2024.01.004","volume":"24","author":"JL Ziegengeist","year":"2024","unstructured":"Ziegengeist JL, Elmes JB, Strassels SA, Patel JN, Moore DC. Alpelisib-induced diabetic ketoacidosis: a pharmacovigilance analysis of the FDA adverse event reporting system and review of the literature. Clin Breast Cancer. 2024;24:e204\u20139. https:\/\/doi.org\/10.1016\/J.CLBC.2024.01.004.","journal-title":"Clin Breast Cancer"},{"key":"6233_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124996","volume":"266","author":"Z Fang","year":"2024","unstructured":"Fang Z, Zhang H, Guo J, Guo J. Overview of therapeutic drug monitoring and clinical practice. Talanta. 2024;266: 124996. https:\/\/doi.org\/10.1016\/j.talanta.2023.124996.","journal-title":"Talanta"},{"key":"6233_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCHROMB.2020.122508","volume":"1163","author":"SW Seo","year":"2021","unstructured":"Seo SW, Kim JM, Han DG, Geum D, Yun H, Yoon IS. A sensitive HPLC-FLD method for the quantification of alpelisib, a novel phosphatidylinositol 3-kinase inhibitor, in rat plasma: drug metabolism and pharmacokinetic evaluation in vitro and in vivo. J Chromatogr B. 2021;1163: 122508. https:\/\/doi.org\/10.1016\/J.JCHROMB.2020.122508.","journal-title":"J Chromatogr B"},{"key":"6233_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2021.743411","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Lan X, Zhao Z, Su X, Zhang Y, Zhou XY, Xu RA. Characterization of alpelisib in rat plasma by a newly developed UPLC-MS\/MS method: application to a drug-drug interaction study. Front Pharmacol. 2021;12: 743411. https:\/\/doi.org\/10.3389\/FPHAR.2021.743411.","journal-title":"Front Pharmacol"},{"key":"6233_CR12","doi-asserted-by":"publisher","unstructured":"Lee S, Kim MS, Jeong JW, Chae J woo, Koo TS, Maeng HJ, Chung SJ, Lee KR, Chae YJ. Bioanalysis of alpelisib using liquid chromatography\u2013tandem mass spectrometry and application to pharmacokinetic study. J Anal Sci Technol. 2022;13:1\u201313.  https:\/\/doi.org\/10.1186\/S40543-022-00340-7.","DOI":"10.1186\/S40543-022-00340-7"},{"key":"6233_CR13","doi-asserted-by":"publisher","first-page":"e5813","DOI":"10.1002\/BMC.5813","volume":"38","author":"V Ghanghav","year":"2024","unstructured":"Ghanghav V, Chawathe A, Chauthe SK, Sharma N. Development of stability-indicating assay method and liquid chromatography-quadrupole-time-of-flight mass spectrometry-based structural characterization of the forced degradation products of alpelisib. Biomed Chromatogr. 2024;38:e5813. https:\/\/doi.org\/10.1002\/BMC.5813.","journal-title":"Biomed Chromatogr"},{"key":"6233_CR14","doi-asserted-by":"publisher","first-page":"126486","DOI":"10.1016\/J.TALANTA.2024.126486","volume":"278","author":"W Bouali","year":"2024","unstructured":"Bouali W, Erk N, Sert B, Harputlu E. Evaluating the simultaneous electrochemical determination of antineoplastic drugs using LaNiO3\/g-C3N4@RGH nanocomposite material. Talanta. 2024;278:126486. https:\/\/doi.org\/10.1016\/J.TALANTA.2024.126486.","journal-title":"Talanta"},{"key":"6233_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/J.MICROC.2024.111014","volume":"204","author":"W Bouali","year":"2024","unstructured":"Bouali W, Kurtay G, Ay\u015fe Gen\u00e7 A, Erk N. Comprehensive analysis of Alpelisib detection: uniting molecular docking, dynamics, and precision electrochemistry at the PEDOT:PSS-carbon paste interface. Microchem J. 2024;204: 111014. https:\/\/doi.org\/10.1016\/J.MICROC.2024.111014.","journal-title":"Microchem J"},{"key":"6233_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.MICROC.2023.109478","volume":"195","author":"W Bouali","year":"2023","unstructured":"Bouali W, Erk N, Genc AA, Ahmed HEH, Soylak M. A new and powerful electrochemical sensing platform based on MWCNTs@Fe3O4@CuAl2O4 for the determination of the anticancer agent Alpelisib in bulk and biological fluids. Microchem J. 2023;195: 109478. https:\/\/doi.org\/10.1016\/J.MICROC.2023.109478.","journal-title":"Microchem J"},{"key":"6233_CR17","doi-asserted-by":"publisher","first-page":"32876","DOI":"10.1039\/D4RA05715E","volume":"14","author":"Z Mlinaric","year":"2024","unstructured":"Mlinaric Z, Turkovic L, Babic I, Silovski T, Kocevar Glavac N, Sertic M. Development, cross-validation and greenness assessment of capillary electrophoresis method for determination of ALP in pharmaceutical dosage forms \u2013 an alternative to liquid chromatography. RSC Adv. 2024;14:32876\u201382. https:\/\/doi.org\/10.1039\/D4RA05715E.","journal-title":"RSC Adv"},{"key":"6233_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050614","volume":"15","author":"L Turkovi\u0107","year":"2022","unstructured":"Turkovi\u0107 L, Bo\u010dkor L, Ekpenyong O, Silovski T, Lovri\u0107 M, Crnkovi\u0107 S, Nigovi\u0107 B, Serti\u0107 M. Development and validation of a novel LC-MS\/MS method for the simultaneous determination of abemaciclib, palbociclib, ribociclib, anastrozole, letrozole, and fulvestrant in plasma samples: a prerequisite for personalized breast cancer treatment. Pharmaceuticals. 2022;15: 614. https:\/\/doi.org\/10.3390\/ph15050614.","journal-title":"Pharmaceuticals"},{"key":"6233_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2021.122655","author":"Y Sato","year":"2021","unstructured":"Sato Y, Shigeta K, Hirasawa T, Sato T, Ogura J, Maekawa M, Ebata A, Hamanaka Y, Tada H, Ishida T, Kikuchi M, Mano N. Establishment of an analytical method for simultaneous quantitation of CDK4\/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS\/MS. J Chromatogr B. 2021. https:\/\/doi.org\/10.1016\/j.jchromb.2021.122655.","journal-title":"J Chromatogr B"},{"key":"6233_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/PH16101445","volume":"16","author":"L Turkovi\u0107","year":"2023","unstructured":"Turkovi\u0107 L, Mutavd\u017ei\u0107 Pavlovi\u0107 D, Mlinari\u0107 Z, Skenderovi\u0107 A, Silovski T, Serti\u0107 M. Optimisation of solid-phase extraction and LC-MS\/MS analysis of six breast cancer drugs in patient plasma samples. Pharmaceuticals. 2023;16: 1445. https:\/\/doi.org\/10.3390\/PH16101445.","journal-title":"Pharmaceuticals"},{"key":"6233_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2024.464698","volume":"1718","author":"Z Mlinari\u0107","year":"2024","unstructured":"Mlinari\u0107 Z, Turkovi\u0107 L, Serti\u0107 M. Dispersive liquid-liquid microextraction followed by sweeping micellar electrokinetic chromatography-tandem mass spectrometry for determination of six breast cancer drugs in human plasma. J Chromatogr A. 2024;1718: 464698. https:\/\/doi.org\/10.1016\/j.chroma.2024.464698.","journal-title":"J Chromatogr A"},{"key":"6233_CR22","doi-asserted-by":"publisher","unstructured":"Turkovi\u0107 L, Koraj N, Mlinari\u0107 Z, Silovski T, Crnkovi\u0107 S, Serti\u0107. Optimisation of dispersive liquid-liquid microextraction for plasma sample preparation in bioanalysis of CDK4\/6 inhibitors in therapeutic combinations for breast cancer treatment. Heliyon. 2023;9(8):e18880. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18880.","DOI":"10.1016\/j.heliyon.2023.e18880"},{"key":"6233_CR23","doi-asserted-by":"publisher","first-page":"100515","DOI":"10.1016\/j.cogsc.2021.100515","volume":"3","author":"M Ranasinghe","year":"2021","unstructured":"Ranasinghe M, Quirino JP. Can we replace liquid chromatography with the greener capillary electrophoresis? Curr Opin Green Sustain Chem. 2021;3:100515. https:\/\/doi.org\/10.1016\/j.cogsc.2021.100515.","journal-title":"Curr Opin Green Sustain Chem"},{"key":"6233_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/J.TALANTA.2015.02.057","volume":"139","author":"D Moreno-Gonz\u00e1lez","year":"2015","unstructured":"Moreno-Gonz\u00e1lez D, Huertas-P\u00e9rez JF, Garc\u00eda-Campa\u00f1a AM, G\u00e1miz-Gracia L. Vortex-assisted surfactant-enhanced emulsification liquid\u2013liquid microextraction for the determination of carbamates in juices by micellar electrokinetic chromatography tandem mass spectrometry. Talanta. 2015;139:174\u201380. https:\/\/doi.org\/10.1016\/J.TALANTA.2015.02.057.","journal-title":"Talanta"},{"key":"6233_CR25","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/J.CHROMA.2010.01.060","volume":"1217","author":"Q Wu","year":"2010","unstructured":"Wu Q, Chang Q, Wu C, Rao H, Zeng X, Wang C, Wang Z. Ultrasound-assisted surfactant-enhanced emulsification microextraction for the determination of carbamate pesticides in water samples by high performance liquid chromatography. J Chromatogr A. 2010;1217:1773\u20138. https:\/\/doi.org\/10.1016\/J.CHROMA.2010.01.060.","journal-title":"J Chromatogr A"},{"key":"6233_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/J.TALANTA.2013.08.034","volume":"117","author":"J Vichapong","year":"2013","unstructured":"Vichapong J, Burakham R, Srijaranai S. Vortex-assisted surfactant-enhanced-emulsification liquid\u2013liquid microextraction with solidification of floating organic droplet combined with HPLC for the determination of neonicotinoid pesticides. Talanta. 2013;117:221\u20138. https:\/\/doi.org\/10.1016\/J.TALANTA.2013.08.034.","journal-title":"Talanta"},{"key":"6233_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/J.TALANTA.2010.08.002","volume":"82","author":"M Moradi","year":"2010","unstructured":"Moradi M, Yamini Y, Esrafili A, Seidi S. Application of surfactant assisted dispersive liquid\u2013liquid microextraction for sample preparation of chlorophenols in water samples. Talanta. 2010;82:1864\u20139. https:\/\/doi.org\/10.1016\/J.TALANTA.2010.08.002.","journal-title":"Talanta"},{"key":"6233_CR28","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1016\/J.CHROMA.2011.08.029","volume":"1218","author":"ZH Yang","year":"2011","unstructured":"Yang ZH, Le LuY, Liu Y, Wu T, Zhou ZQ, Liu DH. Vortex-assisted surfactant-enhanced-emulsification liquid\u2013liquid microextraction. J Chromatogr A. 2011;1218:7071\u20137. https:\/\/doi.org\/10.1016\/J.CHROMA.2011.08.029.","journal-title":"J Chromatogr A"},{"key":"6233_CR29","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/JSSC.201100132","volume":"34","author":"M Moradi","year":"2011","unstructured":"Moradi M, Yamini Y, Baheri T. Analysis of abuse drugs in urine using surfactant-assisted dispersive liquid\u2013liquid microextraction. J Sep Sci. 2011;34:1722\u20139. https:\/\/doi.org\/10.1002\/JSSC.201100132.","journal-title":"J Sep Sci"},{"key":"6233_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.CHROMA.2012.12.017","volume":"1274","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Lee HK. Low-density solvent-based vortex-assisted surfactant-enhanced-emulsification liquid\u2013liquid microextraction combined with gas chromatography\u2013mass spectrometry for the fast determination of phthalate esters in bottled water. J Chromatogr A. 2013;1274:28\u201335. https:\/\/doi.org\/10.1016\/J.CHROMA.2012.12.017.","journal-title":"J Chromatogr A"},{"key":"6233_CR31","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/ELPS.201200104","volume":"33","author":"RH Li","year":"2012","unstructured":"Li RH, Liu DH, Yang ZH, Zhou ZQ, Wang P. Vortex-assisted surfactant-enhanced-emulsification liquid-liquid microextraction for the determination of triazine herbicides in water samples by microemulsion electrokinetic chromatography. Electrophoresis. 2012;33:2176\u201383. https:\/\/doi.org\/10.1002\/ELPS.201200104.","journal-title":"Electrophoresis"},{"key":"6233_CR32","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1021\/JE900916E","volume":"55","author":"C Wang","year":"2010","unstructured":"Wang C, Yan P, Xing H, Jin C, Xiao J-X. Thermodynamics of aggregation of ammonium\/tetraalkylammonium perfluorooctanoates: effect of counterions\u2020. J Chem Eng Data. 2010;55:1994\u20139. https:\/\/doi.org\/10.1021\/JE900916E.","journal-title":"J Chem Eng Data"},{"key":"6233_CR33","doi-asserted-by":"publisher","unstructured":"Kancharla S, Canales E, Alexandridis P. Perfluorooctanoate in aqueous urea solutions: micelle formation, structure, and microenvironment. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20225761.","DOI":"10.3390\/ijms20225761"},{"key":"6233_CR34","doi-asserted-by":"publisher","first-page":"125963","DOI":"10.1016\/J.FOODCHEM.2019.125963","volume":"310","author":"D Moreno-Gonz\u00e1lez","year":"2019","unstructured":"Moreno-Gonz\u00e1lez D, J\u00e1\u010d P, \u0160vec F, Nov\u00e1kov\u00e1 L. Determination of Sudan dyes in chili products by micellar electrokinetic chromatography-MS\/MS using a volatile surfactant. Food Chem. 2019;310:125963. https:\/\/doi.org\/10.1016\/J.FOODCHEM.2019.125963.","journal-title":"Food Chem"},{"key":"6233_CR35","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1200\/JCO.2017.72.7107","volume":"36","author":"D Juric","year":"2018","unstructured":"Juric D, Rodon J, Tabernero J, Janku F, Burris HA, Schellens JHM, Middleton MR, Berlin J, Schuler M, Marta GM, Rugo HS, Ruth SB, Huang A, Bootle D, Demanse D, Blumenstein L, Coughlin C, Quadt C, Baselga J. Phosphatidylinositol 3-kinase a\u2013selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors: results from the first-in-human study. J Clin Oncol. 2018;36:1291\u20139. https:\/\/doi.org\/10.1200\/JCO.2017.72.7107.","journal-title":"J Clin Oncol"},{"key":"6233_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/S10549-010-1022-9","volume":"123","author":"KI Pritchard","year":"2010","unstructured":"Pritchard KI, Rolski J, Papai Z, Mauriac L, Cardoso F, Chang J, Panasci L, Ianuli C, Kahan Z, Fukase K, Lindemann JPO, MacPherson MP, Neven P. Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2). Breast Cancer Res Treat. 2010;123:453\u201361. https:\/\/doi.org\/10.1007\/S10549-010-1022-9.","journal-title":"Breast Cancer Res Treat"},{"key":"6233_CR37","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH harmonised guideline Bioanalytical Method Validation M10. 2022.  https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-ich-guideline-m10-bioanalytical-method-validation-step-2b_en.pdf. Accessed 08 Aug 2025."},{"issue":"13","key":"6233_CR38","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS. Anal Chem. 2003;75(13):3019\u201330. https:\/\/doi.org\/10.1021\/ac020361s.","journal-title":"Anal Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-025-06233-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:02:59Z","timestamp":1770746579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-025-06233-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6233"],"URL":"https:\/\/doi.org\/10.1007\/s00216-025-06233-z","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and received approval from the Ethics Committee of the University of Zagreb Faculty of Pharmacy (Approval No. 251-62-03-19-30; date of approval: April 23, 2019), as well as from the Ethics Committee of the University Hospital Centre Zagreb (Approval No. 02\/21-JG; date of approval: August 20, 2019). Written informed consent was obtained from all participants before their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}